Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine

Published:2020-10 Issue:10 Volume:26 Page:1334-1343
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Buse Dawn C.¹,Yugrakh Marianna S.²,Lee Lulu K.³,Bell Jvawnna⁴,Cohen Joshua M.⁴,Lipton Richard B.⁵

Affiliation:

1. Albert Einstein College of Medicine, Bronx, New York.

2. Department of Neurology, Columbia University Medical Center, New York, New York.

3. Kantar, San Mateo, California.

4. Teva Branded Pharmaceutical Products R&D, West Chester, Pennsylvania.

5. Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine;Headache: The Journal of Head and Face Pain;2024-09-09

2. Changes in use of acute and preventive medications for migraine after erenumab initiation over 12 months: A United States retrospective cohort study;Headache: The Journal of Head and Face Pain;2024-09-09

3. Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial;The Journal of Headache and Pain;2024-05-21

4. Impact of headache frequency and preventive treatment failure on quality of life, disability, and direct and indirect costs among individuals with episodic migraine in the United States;Headache: The Journal of Head and Face Pain;2024-03-24

5. Real-world Impact of Fremanezumab on Migraine-Related Health Care Resource Utilization in Patients with Comorbidities, Acute Medication Overuse, and/or Unsatisfactory Prior Migraine Preventive Response;Pain and Therapy;2024-03-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3